Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPensionPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

InspireMD (NSPR) Work In Process (2016 - 2025)

InspireMD (NSPR) has 13 years of Work In Process data on record, last reported at $733000.0 in Q3 2025.

  • For Q3 2025, Work In Process rose 31.6% year-over-year to $733000.0; the TTM value through Sep 2025 reached $733000.0, up 31.6%, while the annual FY2024 figure was $638000.0, 13.52% up from the prior year.
  • Work In Process reached $733000.0 in Q3 2025 per NSPR's latest filing, down from $865000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $865000.0 in Q2 2025 and bottomed at $223000.0 in Q1 2021.
  • Average Work In Process over 5 years is $535555.6, with a median of $525000.0 recorded in 2023.
  • Peak YoY movement for Work In Process: decreased 20.64% in 2021, then surged 122.87% in 2022.
  • A 5-year view of Work In Process shows it stood at $436000.0 in 2021, then increased by 16.97% to $510000.0 in 2022, then increased by 10.2% to $562000.0 in 2023, then increased by 13.52% to $638000.0 in 2024, then increased by 14.89% to $733000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Work In Process were $733000.0 in Q3 2025, $865000.0 in Q2 2025, and $823000.0 in Q1 2025.